Viyash Scientific Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: VIYASH BSE: 512529

₹229.07

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #44 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Viyash Scientific Limited (this stock)	10,008	161.3	4.9%	13.2%	—	65	27	28

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹10,019 Cr

EV / EBITDA

50.9x

EV / Sales

9.09x

Market cap / Sales

9.08x

Earnings yield

0.62%

Quarterly Financials

Download CSV

Standalone Consolidated

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	354	28	21	₹0.4800
March 31, 2026	372	49	36	₹0.8200
Dec. 31, 2025	342	11	-0	₹0.0000
Sept. 30, 2025	34	4	3	₹0.1200
June 30, 2025	41	5	3	₹
March 31, 2025	42	6	4	₹0.1700
Dec. 31, 2024	36	4	3	₹0.1100
Sept. 30, 2024	42	6	4	₹0.1700
June 30, 2024	58	6	4	₹0.1800
March 31, 2024	37	4	4	₹0.1500
Dec. 31, 2023	42	6	5	₹0.1840
Sept. 30, 2023	49	-1	-1	₹-0.0400
June 30, 2023	40	-9	-7	₹-0.2700

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	368	392	358	46	55	48	58	69	50	56	59	50	55
Operating revenue	354	372	342	34	42	36	42	58	37	42	49	40	47
Other income	15	20	16	12	12	12	16	11	13	13	10	10	8
Operating expenses	307	310	271	37	45	41	44	60	43	46	57	49	53
Operating profit	47	63	70	-3	-3	-4	-2	-2	-6	-4	-8	-9	-6
Operating profit margin	13.3%	16.8%	20.6%	-7.8%	-6.7%	-12.4%	-5.0%	-3.4%	-15.6%	-9.8%	-15.7%	-22.4%	-13.0%
Depreciation	32	31	31	2	2	2	2	2	2	2	2	2	2
Interest	1	3	4	1	1	1	1	1	1	1	1	1	1
Exceptional items, gain / (loss)	—	—	-41	-2	-0	-0	-4	—	—	—	—	-6	—
Profit before tax	28	49	11	4	6	4	6	6	4	6	-1	-9	-1
Tax	7	13	11	1	2	1	2	2	0	2	-0	-2	0
Net profit	21	36	-0	3	4	3	4	4	4	5	-1	-7	-2
EPS	0.48	0.82	0.00	0.12	0.17	0.11	0.17	0.18	0.15	0.18	-0.04	-0.27	-0.07
Net profit (TTM)	60	43	10	14	16	15	17	12	1	-5	-11	-14	-6
EPS (TTM)	1.42	1.11	0.40	0.57	0.63	0.61	0.68	0.47	0.02	-0.20	-0.43	-0.55	-0.25

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,382	116	76
March 31, 2025	178	22	16
March 31, 2024	169	-0	1
March 31, 2023	223	-10	-6

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	—	—	—	229^†	214^†	251^†	247^†	289^†	242^†	181^†	299^†	408^†
Operating revenue	83.8%	38.7%	1,382	178	169	223	220^†	269^†	228^†	168^†	275^†	388^†
Other income	—	—	—	51^†	46^†	28^†	28^†	20^†	14^†	14^†	25^†	20^†
Operating expenses	—	—	—	190^†	195^†	249^†	220^†	233^†	205^†	165^†	262^†	—
Operating profit	—	—	—	-11^†	-27^†	-26^†	-1^†	36^†	22^†	3^†	13^†	—
Operating profit margin	—	—	—	-6.4%^†	-15.8%^†	-11.8%^†	-0.3%^†	13.5%^†	9.8%^†	1.9%^†	4.8%^†	—
Depreciation	—	—	—	9^†	9^†	9^†	10^†	9^†	9^†	7^†	14^†	—
Interest	—	—	—	4^†	4^†	3^†	2^†	3^†	5^†	3^†	4^†	8^†
Exceptional items, gain / (loss)	—	—	—	-5^†	-6^†	0^†	0^†	-3^†	0^†	0^†	-1^†	0^†
Profit before tax	—	22.6%	116	22	-0	-10	16^†	42^†	23^†	6^†	18^†	-0^†
Tax	—	—	—	6^†	-1^†	-4^†	1^†	9^†	—	—	—	—
Net profit	—	18.2%	76	16	1	-6	15^†	33^†	21^†	8^†	—	-0^†
EPS	—	—	—	0.63^†	0.02^†	-0.25^†	0.60^†	1.34^†	0.88^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	—	-6.4%^†	-15.8%^†	-11.8%^†	-0.3%^†	13.5%^†	9.8%^†	1.9%^†	4.8%^†	—
EBIT margin	—	14.6%^†	2.4%^†	-3.2%^†	7.9%^†	16.6%^†	12.2%^†	5.6%^†	8.1%^†	2.2%^†
PBT margin	8.4%	12.4%	-0.1%	-4.4%	7.1%^†	15.6%^†	10.0%^†	3.7%^†	6.5%^†	0.0%^†
Net margin	5.5%	8.9%	0.4%	-2.7%	6.7%^†	12.2%^†	9.4%^†	4.5%^†	—	0.0%^†
Interest coverage	—	6.55x^†	0.95x^†	-2.88x^†	10.75x^†	16.66x^†	5.53x^†	2.93x^†	4.99x^†	1.00x^†
Dividend payout	—	0.0%^†	0.0%^†	—	83.3%^†	0.0%^†	22.7%^†	—	—	—
Earnings retention	—	100.0%^†	100.0%^†	—	16.7%^†	100.0%^†	77.3%^†	—	—	—
Current ratio	2.31x	1.42x	—	—	—	—	—	—	—	—
Quick ratio	1.61x	1.09x	—	—	—	—	—	—	—	—
Debt to equity	0.01x	0.04x	—	—	—	—	—	—	—	—
Return on equity	2.4%	1.4%	—	—	—	—	—	—	—	—
Return on assets	2.1%	1.3%	—	—	—	—	—	—	—	—
Return on capital employed	—	2.3%^†	—	—	—	—	—	—	—	—
Asset turnover	0.38x	0.15x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	119	-107	-7	101	18
March 31, 2025	-1	-0	1	12	-13
March 31, 2024	-27	5	22	10	-36
March 31, 2023	38	-51	0	9	29
March 31, 2022	9	-4	7	6	3

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	3,655	3,189	3,102	26	6	962	416	21	803	293
March 31, 2025	1,222	1,143	1,093	44	0	108	76	0	45	25
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.